Jeffrey Levy
Critical Care Medicine · Hollywood, FLNPI 1679686950
Payments from drug & device makers
Across 358 payments — averaging $53,051 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$13.5M
- Pfizer$2.8M
- Biocryst Pharmaceuticals, Inc.$2.2M
- Novartis$347K
- Genentech, Inc.$249K
- Eagle Pharmaceuticals, Inc.$350
Across 10 payments — averaging $147,064 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$916K
- Assertio Therapeutics, Inc.$551K
- Pfizer$3K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 274 | $13,460,301 |
| Pfizer | 28 | $2,783,411 |
| Biocryst Pharmaceuticals, Inc. | 40 | $2,152,362 |
| Novartis | 9 | $346,546 |
| Genentech, Inc. | 6 | $249,400 |
| Eagle Pharmaceuticals, Inc. | 1 | $350 |
How this compares
$18,992,369 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Other critical care medicine in Hollywood
- Ahmad AswadMiami$6.6M
- George DuvallVero Beach$6M
- Fortune AlabiKissimmee$3.2M
- Carlos VacaMiami$3M
- Debabrata BandyopadhyayTampa$1.9M
- Christopher HardenGainesville$713K
- Fred UmehKissimmee$682K
- Ali AtayaGainesville$672K
- George AzarFt Lauderdale$669K
- Louis GuzziOrlando$635K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.